Furthermore, the E6 and E7 HPV oncoproteins are known to correlate with PIK3CA mutations or amplifications in over half of HPV-positive HNSCC, leading to drug resistance. The gene discussed is PIK3CA; the disease is head and neck squamous cell carcinoma.